Salud financiera de hoja de balance de Dolby Laboratories
Salud financiera controles de criterios 6/6
Dolby Laboratories tiene un patrimonio de accionistas total de $2.4B y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $2.9B y $573.2M respectivamente. El BAIT de Dolby Laboratories es de $241.3M, por lo que su ratio de cobertura de intereses es de -7.4. Tiene efectivo e inversiones a corto plazo que ascienden a $797.6M.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | -7.4x |
| Efectivo | US$797.64m |
| Patrimonio | US$2.36b |
| Total pasivo | US$573.22m |
| Activos totales | US$2.94b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist
Apr 16
Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate
Mar 17Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)
Mar 01Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye
Feb 09What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jan 31With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For
Jan 15The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising
Dec 28Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue
Dec 06A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Nov 18At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?
Oct 11Dolby Laboratories: High P/E Is Not Justified, A Hold For Now
Sep 13The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
Aug 03What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jul 12Dolby Laboratories Sees Return To Growth Ahead
Jun 22Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture
May 04A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Apr 14Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Mar 29Dolby Laboratories goes ex-dividend on Monday
Feb 10Dolby Laboratories FQ1 2023 Earnings Preview
Feb 01Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company
Jan 24Dolby: A 2023 Update, And Still A 'Hold'
Jan 11An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 25% Undervalued
Jan 09Is Dolby Laboratories, Inc. (NYSE:DLB) Potentially Undervalued?
Dec 25Dolby Laboratories' (NYSE:DLB) Dividend Will Be Increased To $0.27
Nov 21Dolby: Great Moat But Not Such A Great Investment Idea
Oct 29Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 38% Undervaluation?
Oct 05Dolby Laboratories Seeks Broader Growth As Macro Conditions Weigh
Sep 28At US$72.98, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?
Sep 20Be Wary Of Dolby Laboratories (NYSE:DLB) And Its Returns On Capital
Aug 20Dolby Laboratories goes ex-dividend tomorrow
Aug 19Dolby Laboratories Non-GAAP EPS of $0.68 beats by $0.09, revenue of $289.59M misses by $4.44M
Aug 09Dolby: Is Low-Yield Growth Worth It In This Market?
Jul 17An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 41% Undervalued
Jul 03Is It Time To Consider Buying Dolby Laboratories, Inc. (NYSE:DLB)?
Jun 17Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($1.5B) de DLB superan a sus pasivos a corto plazo ($394.1M).
Pasivo a largo plazo: Los activos a corto plazo de DLB ($1.5B) superan a sus pasivos a largo plazo ($179.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: DLB está libre de deudas.
Reducción de la deuda: DLB no ha tenido ninguna deuda en los últimos 5 años.
Cobertura de la deuda: DLB no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.
Cobertura de intereses: DLB no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.